Guidelines to use of Plasma Levels From a Clinical Perspective

  • Theodore Van Putten


If plasma levels of antipsychotic drug could be related in some way to clinical outcome, the pharmacotherapy of schizophrenia might become less of a frontier profession. So far, all that appears to be firmly established is that plasma levels of antipsychotic drugs vary enormously between patients.


Plasma Level Antipsychotic Drug Schizophrenic Patient High Plasma Level Troublesome Side Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    P. R. A. May and T. Van Putten, Plasma and saliva levels of chlorpromazine in schizophrenia: a critical review of the literature. Arch. Gen. Psychiatr. 35:477, (1978).PubMedCrossRefGoogle Scholar
  2. 2.
    J. M. Davis, S. Erickson and H. Dekirmenjian, Plasma levels of antipsychotic drugs and clinical response, in “Psychopharmacology: A Generation of Progress,” M. A. Lipton, A. DiMascio and K. F. Killam, eds., Raven, New York (1978).Google Scholar
  3. 3.
    M. W. Dysken, J. I. Javaid and S. S. Chang, Fluphenazine pharmacokinetics and therapeutic response, Psychopharmacology 73:205 (1981).PubMedCrossRefGoogle Scholar
  4. 4.
    J. R. Magliozzi, L. E. Hollister, K. V. Arnold and G. M. Earle, Relationship of serum haloperidol levels to clinical response in schizophrenic patients, Am. J. Psychiatr. 138:365 (1981).PubMedGoogle Scholar
  5. 5.
    Extein, K. A. Augusthy and M. S. Gold, Plasma haloperidol levels and clinical response in acute schizophrenia, Psychopharm. Bull. 18:156 (1982).Google Scholar
  6. 6.
    R. C. Smith, What is the clinical value of a neuroleptic blood level? Presented at the American College of Neuropsycho-pharmacology, Dec. 17, 1981.Google Scholar
  7. 7.
    T. Van Putten, P. R. A. May, S. R. Marder, J. N. Wilkens and B. J. Rosenberg, Plasma levels of thiothixene by radioreceptor assays: clinical usefulness, Psychopharmacology 79:40 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    T. Van Putten, P. R. A. May and D. J. Jenden, Does a plasma level of chlorpromazine help? Psychol. Med. 11:729 (1981).PubMedCrossRefGoogle Scholar
  9. 9.
    P. R. A. May, T. Van Putten, D. J. Jenden, C. Yale, and W. J. Dixon, Chlorpromazine in blood and saliva levels and the outcome of treatment in schizophrenic patients, Arch. Gen. Psychiatr. 38, 202 (1981).PubMedCrossRefGoogle Scholar
  10. 10.
    R. T. Ruben, A. Forsman and J. Heykantz, Serum haloperidol determinations in psychiatric patients: comparison of methods and correlation with serum prolactin, Arch. Gen. Psychiatr. 37:1069 (1980).CrossRefGoogle Scholar
  11. 11.
    Creese, D. R. Burt and S. H. Snyder, A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood, Nature 270:180 (1977).PubMedCrossRefGoogle Scholar
  12. 12.
    J. E. Overall and D. R. Gorham, The brief psychiatric rating scale, Psychol. Rep. 10:799 (1962).CrossRefGoogle Scholar
  13. 13.
    G. Honigfeld and C. J. Klett, The nurses’ observation scale for inpatient evaluation: a new scale for measuring improvement in chronic schizophrenia J. Clin. Psychol. 21:65 (1965).PubMedCrossRefGoogle Scholar
  14. 14.
    J. A. Yesavage, J. Becker and P. D. Werner, Serum level monitoring of thiothixine in schizophrenia: acute single-dose levels at fixed doses, Am. J. Psychiatr. 139:174 (1982).PubMedGoogle Scholar
  15. 15.
    L. Hollister, Plasma levels and the management of chronic refractory schizophrenics. Presented at VII World Congress of Psychiatry, Vienna, 12 July, 1983.Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Theodore Van Putten
    • 1
  1. 1.Brentwood Veterans Medical CenterLos AngelesUSA

Personalised recommendations